Keyphrases
ACE Inhibitor Therapy
16%
Adrenergic Receptors
16%
Ancillary
16%
Angiotensin II (Ang II)
100%
Angiotensin II Infusion
100%
Angiotensin II Type 1 Receptor (AT1R)
16%
Beta-blockers
100%
Block Properties
16%
Carvedilol
100%
Chronic Heart Failure
16%
Enalapril
16%
Intravenous Injection
16%
Left Ventricular Ejection Fraction
16%
Maximum Tolerated Dose
16%
Metoprolol
66%
New York Heart Association Class
16%
Non-selective
16%
Patients with Chronic Heart Failure
100%
Radial Artery
33%
Selective Antagonist
16%
Synergistic Interaction
16%
Systolic Pressure
33%
Vascular Reactivity
16%
Vasopressor Responses
100%
Nursing and Health Professions
Adrenergic Receptor
11%
Angiotensin Blood Level
11%
Angiotensin II
100%
Carvedilol
66%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Enalapril
11%
Heart Left Ventricle Ejection Fraction
11%
Hypertensive Factor
100%
Infusion
100%
Intravenous Drug Administration
11%
Maximum Tolerated Dose
11%
Metoprolol
44%
New York Heart Association Class
11%
Receptor
11%
Systolic Blood Pressure
22%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenergic Receptor
11%
Angiotensin II
100%
Carvedilol
66%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Enalapril
11%
Hypertensive Factor
100%
Maximum Tolerated Dose
11%
Metoprolol
44%
Receptor
11%
Synergism
11%